The U.S. May Not Be Able to Purchase More N95 Respirators from 3M

President Trump invoked the Defense Production Act on Thursday in an attempt to obtain more N95 respirators produced by 3M Co, which are capable of protecting healthcare workers and first responders from the coronavirus (COVID-19).
 
Alison Casey, medical devices analyst at GlobalData, a leading data and analytics company, said:
 
“Due to global shortages, 3M Co have already ramped up their production of N95 respirators, doubling their normal output. The company is currently manufacturing almost 100 million N95 respiratory per month globally, 35 million of which are produced in the US. Furthermore, 3M Co dominates the US market for the FDA-approved N95 respirator devices accounting for approximately 64% of sales.
 
“Despite this increase in production, the head of Florida’s Division of Emergency Management Jared Moskowitz claimed in a Fox News interview that the State still can’t obtain the N95 respirators it needs because 3M Co have lost control of their distributor system. Moskowitz claims that authorized distributors of N95 masks in the US are prioritizing foreign countries who offer to pay in cash and that 3M Co failed to issue guidance to prevent this behavior. These supply issues may be what President Trump was referring to yesterday when he tweeted: ‘We hit 3M hard today after seeing what they were doing with their Masks’.
 
“Even if these distributor issues are solved, it may not be possible for the US to purchase enough of 3M Co’s N95 respirators, due to the fact that the company previously outsourced production of approximately two-thirds of its N95 respirators to other countries, which are also suffering from the pandemic. Should the Defense Production Act not be as successful at obtaining more of 3M Co’s N95 respirators as President Trump hopes, it remains to be seen whether other key market players such as Owens & Minor will be targeted next.”